Interferon beta, a group of widely-prescribed drugs for treating multiple sclerosis (MS), may not slow long-term progression of the diseaseMSJournal of the American Medical Association, JAMA







question the use of interferon beta drugs to prevent or delay long-term disability in MS patients





JAMA



despite the unreliable explicit prognostic criteria, neurologists and patients in British Columbia seem to have made the right choices